DB Wealth Management Group’s ResMed RMD Stock Holding History

DB Wealth Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$170K	Hold	987	–	–	0.1%	92
2023 Q3	$146K	Hold	987	–	–	0.09%	95
2023 Q2	$216K	Hold	987	–	–	0.13%	82
2023 Q1	$216K	Hold	987	–	–	0.14%	80
2022 Q4	$205K	Hold	987	–	–	0.13%	79
2022 Q3	$215K	Hold	987	–	–	0.15%	79
2022 Q2	$207K	Hold	987	–	–	0.14%	81
2022 Q1	$239K	Sell	987 -30	-3%	-$7.26K	0.14%	79
2021 Q4	$265K	Hold	1,017	–	–	0.16%	77
2021 Q3	$268K	Hold	1,017	–	–	0.17%	74
2021 Q2	$251K	Hold	1,017	–	–	0.16%	80
2021 Q1	$197K	Sell	1,017 -33	-3%	-$6.62K	0.14%	87
2020 Q4	$223K	Buy	+1,050	New	+$209K	0.16%	83

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DB Wealth Management Group's RMD Position: Q4 2023 in Review

DB Wealth Management Group held its ResMed (RMD) position steady in Q4 2023 at 987 shares worth $170K. The position accounts for 0.1% of the portfolio, ranked #92.

DB Wealth Management Group first reported a position in RMD in Q4 2020 and has held it in 13 quarters since. The position peaked at $268K in Q3 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

DB Wealth Management Group held 987 shares of ResMed worth $170K as of Q4 2023.
DB Wealth Management Group left its ResMed share count unchanged in Q4 2023.
ResMed made up 0.1% of DB Wealth Management Group's portfolio in Q4 2023, its #92 holding.
DB Wealth Management Group first reported a position in ResMed in Q4 2020 and has held it in 13 quarters since.
DB Wealth Management Group's ResMed position peaked at $268K in Q3 2021.
687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.